Meeting Coverage


International Association for the Study of Lung Cancer

IMRT Best for Locally Advanced NSCLC, Study Suggests

Technique reduces risk of severe lung toxicity and radiation to the heart compared with 3D-CRT

WCLC over a photo of Suntec Singapore Convention & Exhibition Centre.

Latest IASLC Meeting Coverage

Novel Antibody-Drug Conjugate Shows Efficacy in Advanced EGFR-Mutated NSCLC

Confirmed responses reached 29.8% in heavily pretreated patients

September 13, 2023
Study Questions Use of Aggressive Surgery in Early Mesothelioma

Randomized data suggest surgery increases risk of death by 28% over first 42 months

September 12, 2023
Adding First-Line Chemo Boosts PFS in EGFR-Mutant Lung Cancer

Osimertinib plus chemotherapy improved PFS by nearly 9 months versus targeted agent alone

September 12, 2023
First-Line Triplet Yields 'Striking' OS Result in Extensive-Stage SCLC

Median overall survival reached 19.3 months in Chinese trial

September 11, 2023
'Clinically Meaningful' Improvement in SCLC Patients With Pembrolizumab/Chemo Combo

Long-term follow-up shows continued survival benefit as first-line treatment

August 11, 2022
Triple Therapy Continues to Impress in Metastatic NSCLC With High-Risk Mutations

Meaningful survival boosts in POSEIDON trial of front-line durvalumab, tremelimumab, and chemo

August 10, 2022
Survey: 77% of Women With Lung Cancer Report Sexual Dysfunction

Results show need to integrate sexual health into care, researcher says

August 9, 2022
Neodjuvant Chemoimmunotherapy Takes Another Step Forward in Stage IIIA-B NSCLC

Phase II trial supports neoadjuvant nivolumab plus chemotherapy

August 9, 2022
New Data Bolster Atezolizumab as Adjuvant Tx in NSCLC

Overall survival benefit now demonstrated

August 9, 2022
Low-Dose Sotorasib 'Lead-in' Strategy Promising in NSCLC Subset

Early phase results set the stage for KRAS/immune-targeted combo as potential first-line option

August 8, 2022
Sublobar Resection the 'New Standard of Care' in Small-Sized NSCLC?

Large randomized study shows non-inferiority to lobectomy

August 8, 2022
Young Adults With NSCLC More Apt to Get Advanced Disease Diagnosis

Study finds minimal improvements in the early diagnosis of young patients with lung cancer

August 7, 2022
More Help on the Way for Lung Cancers With Exon 20 Mutations?

Early trials of DZD9008 demonstrated responses in over a third of patients

September 15, 2021
Cancer Vaccine May Boost Anti-EGFR Efficacy in Non-Small Cell Lung Cancer

More than 90% disease control rate, hint of improved PFS in pilot trial

September 14, 2021